Find your next paid study

GI Innovation, Inc.NCT05824975

~$150 – $4,200

Actual pay is set by the research site.

Healthy Adult Participants

The SEAS Study: Sensory Engagement and Activation During Noninvasive Stimulation

Early feasibility study to establish quantitative physiological markers correlated with noninvasive stimulation.

University of MinnesotaNCT07606573

Actual pay is set by the research site.

Metastatic Solid TumorRecurrent Solid TumorAdvanced Solid Tumor+11 more

A Phase 1a/1b Study of LY4052031, an Antibody-Drug Conjugate Targeting Nectin-4, in Participants With Advanced or Metastatic Urothelial Carcinoma or Other Solid Tumors

The purpose of this study is to find out whether the study drug, LY4052031, is safe, tolerable and effective in participants with advanced, or metastatic solid…

Eli Lilly and CompanyNCT06465069

~$150 – $4,500

Actual pay is set by the research site.

Advanced Cutaneous MelanomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+1 more

A Single-Center, Prospective Pilot Trial of Circadian-Optimized Light Therapy (COLT) in Patients Undergoing Tumor-Infiltrating Lymphocyte (TIL) Therapy for Metastatic Melanoma

This phase I trial tests the effect of Circadian-Optimized Light Therapy (COLT) in conjunction with standard of care tumor-infiltrating lymphocytes (TIL) thera…

City of Hope Medical CenterNCT07628894

~$150 – $3,000

Actual pay is set by the research site.

Investigating the Longitudinal Relationships Between Visual Pathway Injury, Radiological and Blood Biomarkers in Multiple Sclerosis and Related Disorders

This study is being conducted to investigate risk factors for disability progression in Multiple Sclerosis and related disorders (MSRD). The primary goal is to…

Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Primary Progressive+8 more

Cedars-Sinai Medical CenterNCT05204459

Actual pay is set by the research site.

Phase 3

A Phase 3, Multicenter, Open-label Extension Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa

This is a study to evaluate the long-term safety, tolerability, and efficacy of sonelokimab in participants with moderate to severe hidradenitis suppurativa wh…

Hidradenitis Suppurativa

MoonLake Immunotherapeutics AGNCT07007637

~$50 – $2,100

Actual pay is set by the research site.

Phase 1/1b Study of the Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Clinical Activity of Lunresertib Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid Tumors

The primary purpose of this study is to assess the safety and tolerability of lunresertib alone and in combination with RP-3500 or in combination with Debio 01…

Advanced Solid Tumor

Debiopharm International SANCT04855656

~$150 – $4,500

Actual pay is set by the research site.

A Phase 1/2 Open-label Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of ARV-6723 Administered as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors

This is a study to evaluate the safety and potential anti-tumor activity of an investigational drug called ARV-6723, in participants with advanced solid tumors…

Advanced Solid Tumor

~$150 – $4,200

Actual pay is set by the research site.

Arvinas Inc.NCT07749586

Recurrent Ovarian High Grade Serous AdenocarcinomaRecurrent Platinum-Resistant Ovarian Carcinoma

A Phase 1/1b Dose Escalation Study of Abemaciclib and Olaparib for Recurrent Platinum-Resistant Ovarian Cancer

This phase I/Ib trial identifies the side effects and best dose of abemaciclib when given together with olaparib in treating patients with ovarian cancer that …

National Cancer Institute (NCI)NCT04633239

~$150 – $2,700

Actual pay is set by the research site.

Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB) EVANESCE-II

A study to evaluate the safety and effectiveness of FemPulse System

Overactive Bladder (OAB)

FemPulse CorporationNCT07195656

~$10 – $1,050

Actual pay is set by the research site.

Substance UseHarm ReductionAdolescent Behavior

A Randomized Clinical Trial of a Novel Drug Education and Diversion Program (iDECIDE) for Middle and High School Students

The primary goal of this study is to test the effectiveness of the iDECIDE (Drug Education Curriculum: Intervention, Diversion, and Empowerment) curriculum, a …

Massachusetts General HospitalNCT06115746

Actual pay is set by the research site.

Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support

The proposed project will have two separate cohorts. The first will be to perform a more in-depth qualitative assessment of the barriers and facilitators for t…

Bladder Cancer